Therapy insight: management of Graves' disease during pregnancy.
about
Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevancePropylthiouracil is teratogenic in murine embryosFetal and neonatal thyrotoxicosis.A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugs.Pregnancy and thyroid cancer: ultrasound study of foetal thyroid.Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance.Thyroid physiology and common diseases in pregnancy: review of literatureManagement of Hyperthyroidism in Pregnancy: Results of a Survey among Members of the European Thyroid AssociationEvaluation of developmental toxicity of propylthiouracil and methimazole.Embolic suppurative thyroiditis with concurrent carcinoma in pregnancy: lessons in management through a case report.Block and replace therapy using propylthiouracil and levothyroxine for Graves' disease during pregnancy.Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos.Clinical review: Clinical utility of TSH receptor antibodies.Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States.Complex chimerism: pregnancy after solid organ transplantationFactors Associated With Mortality of Thyroid Storm: Analysis Using a National Inpatient Database in Japan.Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy.Thyroid physiology and autoimmunity in pregnancy and after delivery.The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Reproduction and autoimmune disease: important translational implications from embryo-maternal interaction.Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.Transient congenital hypothyroidism.Neonatal Thyrotoxicosis with Tricuspid Valve Regurgitation and Hydrops in a Preterm Infant Born to a Mother with Graves' Disease.Women with high early pregnancy urinary iodine levels have an increased risk of hyperthyroid newborns: the population-based Generation R StudyDrug development for use during pregnancy: impact of the placenta
P2860
Q21285111-F6485BD2-BF34-4F0C-9CFF-EDAE54E49DEDQ28482407-DA534271-8CFA-439E-AB83-E54B0FDBC908Q33411594-060641D8-E95C-4BDA-9F05-C64704712FF7Q33606627-2055BB49-74AC-4D2A-8FE7-06A8EF60B576Q33844128-D96F495F-E221-4A14-BDD1-DF826E0949E7Q33854441-5B61440F-5594-4B89-8588-D4A0646B9B56Q34319888-72436917-8D6B-43FC-B42C-B9A1E5DA413DQ34562767-011D0886-563E-4D6F-ADA3-17B12BF6CEF7Q34965489-F0598613-E844-45C9-9764-54DA7E761683Q35147548-DA71201C-FDDC-4081-917E-AB7EB57CEC24Q36107846-F3832117-45ED-4001-9C2E-7F764F4B00D4Q36534402-A445F941-E300-4D68-9A7D-3DEEF4C48CD3Q36885833-8EFD5760-E6FF-45B5-8F02-6FA88B7C1982Q36910874-0A28BEA5-B2E1-4EC3-8859-0902F095A75FQ37196104-CF4DBEE1-40D3-49D5-95DB-981DBB211F0DQ37206234-1B8CC835-9AC4-405E-9371-3AEB5D22A6C5Q37260155-E11CEBA9-7296-479A-9EB8-BA0335DD08E5Q37927084-A15A38AF-E52B-4E37-B190-79B14644346DQ38107399-7843CDBD-CDD4-4D94-84F2-6279548AD4FFQ38119553-6A7557FD-62CE-4226-BDB6-0868CE5B059CQ38243292-F83800C3-8292-4E0B-B2E8-2B13C65A8697Q38363475-6460C7E1-C6B0-4252-8A34-B09C00FF01E9Q55058154-9EFFB318-78CB-4842-9566-212AA96E77EBQ57337546-D5D28176-7D36-4E0F-A658-C460875E3F29Q58392274-ACEEDA8C-22F8-4D72-B007-72B5CFA390CC
P2860
Therapy insight: management of Graves' disease during pregnancy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapy insight: management of Graves' disease during pregnancy.
@en
type
label
Therapy insight: management of Graves' disease during pregnancy.
@en
prefLabel
Therapy insight: management of Graves' disease during pregnancy.
@en
P2860
P356
P1476
Therapy insight: management of Graves' disease during pregnancy.
@en
P2093
Grace W Chan
Susan J Mandel
P2860
P304
P356
10.1038/NCPENDMET0508
P577
2007-06-01T00:00:00Z